Molecular Partners AG
NASDAQ:MOLN

Watchlist Manager
Molecular Partners AG Logo
Molecular Partners AG
NASDAQ:MOLN
Watchlist
Price: 5.6898 USD -2.21% Market Closed
Market Cap: 188.8m USD
Have any thoughts about
Molecular Partners AG?
Write Note

Wall Street
Price Targets

MOLN Price Targets Summary
Molecular Partners AG

Wall Street analysts forecast MOLN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MOLN is 10.0464 USD with a low forecast of 3.3159 USD and a high forecast of 17.2365 USD.

Lowest
Price Target
3.3159 USD
42% Downside
Average
Price Target
10.0464 USD
77% Upside
Highest
Price Target
17.2365 USD
203% Upside
Molecular Partners AG Competitors:
Price Targets
LTRN
Lantern Pharma Inc.
527% Upside
4882
Perseus Proteomics Inc
27% Upside
MCRB
Seres Therapeutics Inc
498% Upside
1167
Jacobio Pharmaceuticals Group Co Ltd
114% Upside
IDYA
IDEAYA Biosciences Inc
86% Upside
MGNX
MacroGenics Inc
80% Upside
BIOCON
Biocon Ltd
1% Downside
FOLD
Amicus Therapeutics Inc
70% Upside

Revenue
Forecast

Revenue Estimate
Molecular Partners AG

For the last 8 years the compound annual growth rate for Molecular Partners AG's revenue is -16%. The projected CAGR for the next 3 years is 42%.

-16%
Past Growth
42%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Molecular Partners AG

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Molecular Partners AG

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MOLN's stock price target?
Price Target
10.0464 USD

According to Wall Street analysts, the average 1-year price target for MOLN is 10.0464 USD with a low forecast of 3.3159 USD and a high forecast of 17.2365 USD.

What is Molecular Partners AG's Revenue forecast?
Projected CAGR
42%

For the last 8 years the compound annual growth rate for Molecular Partners AG's revenue is -16%. The projected CAGR for the next 3 years is 42%.

Back to Top